Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sifang Chen

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Scientific Reports|July 15, 2025
Retraction Note: Reducing PKCδ inhibits tumor growth through growth hormone by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenomaXi Chen, Jianyao Mao, Liwei Zhou, et al.
Scientific Reports|April 20, 2022
Identification of ubiquitin-specific protease 32 as an oncogene in glioblastoma and the underlying mechanismsSifang Chen, Xi Chen, Zhangyu Li, et al.
Scientific Reports|April 3, 2025
Reducing PKCδ inhibits tumor growth through growth hormone by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenomaXi Chen, Jianyao Mao, Liwei Zhou, et al.
Frontiers in Aging Neuroscience|September 6, 2021
Association Between Body Mass Index and Intracranial Aneurysm Rupture: A Multicenter Retrospective StudySifang Chen, Jianyao Mao, Xi Chen, et al.
Oncology Letters|March 23, 2026
Integrated proteomic and metabolomic profiling reveals molecular signatures underlying invasiveness in non-functioning pituitary adenomasJianyao Mao, Xi Chen, Wentao Zheng, et al.
Journal of Neurosurgery|May 1, 2026
Subthalamic nucleus deep brain stimulation in Meige syndrome: mapping the optimal stimulation sites and network targetsWentao Zheng, Chen Wang, Xi Chen, et al.
Cancer Management and Research|September 10, 2025
Multicenter Development of a Clinical-Molecular Nomogram for Predicting Survival in Lung Cancer Brain Metastasis PatientsXiansheng Qiu, Zhenwei Lu, Chongfei Li, et al.
Cell Death & Disease|October 1, 2024
CD2AP promotes the progression of glioblastoma multiforme via TRIM5-mediated NF-kB signalingLiang Zhang, Jiawei He, Wentao Zhao, et al.
Frontiers in Genetics|June 24, 2026
LPIN3 emerges as a diagnostic biomarker in Moyamoya disease revealing immune-lipid metabolic crosstalkZhenwei Lu, Xiansheng Qiu, Liwei Zhou, et al.
Cell Death & Disease|January 9, 2023
The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrestWenpeng Zhao, Liang Zhang, Yaya Zhang, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Scientific Reports|July 15, 2025
Retraction Note: Reducing PKCδ inhibits tumor growth through growth hormone by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenomaXi Chen, Jianyao Mao, Liwei Zhou, et al.
Scientific Reports|April 20, 2022
Identification of ubiquitin-specific protease 32 as an oncogene in glioblastoma and the underlying mechanismsSifang Chen, Xi Chen, Zhangyu Li, et al.
Scientific Reports|April 3, 2025
Reducing PKCδ inhibits tumor growth through growth hormone by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenomaXi Chen, Jianyao Mao, Liwei Zhou, et al.
Frontiers in Aging Neuroscience|September 6, 2021
Association Between Body Mass Index and Intracranial Aneurysm Rupture: A Multicenter Retrospective StudySifang Chen, Jianyao Mao, Xi Chen, et al.
Oncology Letters|March 23, 2026
Integrated proteomic and metabolomic profiling reveals molecular signatures underlying invasiveness in non-functioning pituitary adenomasJianyao Mao, Xi Chen, Wentao Zheng, et al.
Journal of Neurosurgery|May 1, 2026
Subthalamic nucleus deep brain stimulation in Meige syndrome: mapping the optimal stimulation sites and network targetsWentao Zheng, Chen Wang, Xi Chen, et al.
Cancer Management and Research|September 10, 2025
Multicenter Development of a Clinical-Molecular Nomogram for Predicting Survival in Lung Cancer Brain Metastasis PatientsXiansheng Qiu, Zhenwei Lu, Chongfei Li, et al.
Cell Death & Disease|October 1, 2024
CD2AP promotes the progression of glioblastoma multiforme via TRIM5-mediated NF-kB signalingLiang Zhang, Jiawei He, Wentao Zhao, et al.
Frontiers in Genetics|June 24, 2026
LPIN3 emerges as a diagnostic biomarker in Moyamoya disease revealing immune-lipid metabolic crosstalkZhenwei Lu, Xiansheng Qiu, Liwei Zhou, et al.
Cell Death & Disease|January 9, 2023
The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrestWenpeng Zhao, Liang Zhang, Yaya Zhang, et al.
Pageof 5